Corewell Health and Quest Diagnostics have announced a joint venture to enhance laboratory services in Michigan, combining advanced technologies and management expertise to improve patient care across the state.

Target Information

Corewell Health and Quest Diagnostics have entered into a joint venture aimed at enhancing laboratory services throughout Michigan. This partnership will establish the Diagnostic Lab of Michigan, LLC, which will be headquartered in a cutting-edge 100,000-square-foot laboratory at the Corewell Health Southfield Center in Southfield, Michigan. The facility will incorporate advanced technologies, including automated microbiology and high-throughput molecular testing, thereby expanding the quality and accessibility of laboratory services for both physicians and patients.

Under this joint venture, Quest will also take responsibility for managing the laboratory operations of Corewell Health's 21 hospital labs, ensuring consistent service across the state. This strategic collaboration aims to improve healthcare outcomes through innovative solutions while maintaining affordability and accessibility for all residents in Michigan.

Industry Overview in Michigan

The healthcare industry in Michigan is continually evolving, propelled by advancements in technology and a rising demand for accessible medical services. As one of the larger states in the Midwest, Michigan boasts a robust healthcare infrastructure tha

View Source

Similar Deals

Kaiser Permanente Renown Health

2025

Joint Venture HMO Medical Centers United States of America
InnovAge Tampa General Hospital

2025

Joint Venture Residential & Long-Term Care United States of America
InfuSystem Holdings, Inc. ChemoMouthpiece, LLC

2024

Joint Venture Medical Devices & Implants United States of America
CareSource Lakeland Care, Inc.

2024

Joint Venture Residential & Long-Term Care United States of America
Emory Healthcare Houston Healthcare

2024

Joint Venture Hospitals, Clinics & Primary Care Services United States of America
Sagard Healthcare HEMGENIX®

2023

Joint Venture Bio Therapeutic Drugs United States of America

Quest Diagnostics

invested in

Corewell Health

in 2025

in a Joint Venture deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert